PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FSHCX vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FSHCX and JNJ is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

FSHCX vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Health Care Services Portfolio (FSHCX) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

3,000.00%3,500.00%4,000.00%4,500.00%5,000.00%AugustSeptemberOctoberNovemberDecember2025
2,979.07%
4,764.68%
FSHCX
JNJ

Key characteristics

Sharpe Ratio

FSHCX:

-1.04

JNJ:

-0.35

Sortino Ratio

FSHCX:

-1.30

JNJ:

-0.41

Omega Ratio

FSHCX:

0.81

JNJ:

0.95

Calmar Ratio

FSHCX:

-0.67

JNJ:

-0.31

Martin Ratio

FSHCX:

-2.03

JNJ:

-0.79

Ulcer Index

FSHCX:

10.07%

JNJ:

6.88%

Daily Std Dev

FSHCX:

19.56%

JNJ:

15.48%

Max Drawdown

FSHCX:

-57.77%

JNJ:

-52.60%

Current Drawdown

FSHCX:

-26.56%

JNJ:

-14.32%

Returns By Period

In the year-to-date period, FSHCX achieves a 5.50% return, which is significantly higher than JNJ's 1.67% return. Over the past 10 years, FSHCX has underperformed JNJ with an annualized return of 2.85%, while JNJ has yielded a comparatively higher 6.72% annualized return.


FSHCX

YTD

5.50%

1M

-3.96%

6M

-16.42%

1Y

-18.55%

5Y*

-0.03%

10Y*

2.85%

JNJ

YTD

1.67%

1M

1.58%

6M

-3.46%

1Y

-5.91%

5Y*

2.52%

10Y*

6.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FSHCX vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSHCX
The Risk-Adjusted Performance Rank of FSHCX is 00
Overall Rank
The Sharpe Ratio Rank of FSHCX is 00
Sharpe Ratio Rank
The Sortino Ratio Rank of FSHCX is 00
Sortino Ratio Rank
The Omega Ratio Rank of FSHCX is 00
Omega Ratio Rank
The Calmar Ratio Rank of FSHCX is 00
Calmar Ratio Rank
The Martin Ratio Rank of FSHCX is 00
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2626
Overall Rank
The Sharpe Ratio Rank of JNJ is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 2222
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 2323
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2828
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FSHCX vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Health Care Services Portfolio (FSHCX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FSHCX, currently valued at -1.04, compared to the broader market-1.000.001.002.003.004.00-1.04-0.35
The chart of Sortino ratio for FSHCX, currently valued at -1.30, compared to the broader market0.005.0010.00-1.30-0.41
The chart of Omega ratio for FSHCX, currently valued at 0.81, compared to the broader market1.002.003.004.000.810.95
The chart of Calmar ratio for FSHCX, currently valued at -0.67, compared to the broader market0.005.0010.0015.0020.00-0.67-0.31
The chart of Martin ratio for FSHCX, currently valued at -2.03, compared to the broader market0.0020.0040.0060.0080.00-2.03-0.79
FSHCX
JNJ

The current FSHCX Sharpe Ratio is -1.04, which is lower than the JNJ Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of FSHCX and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-1.04
-0.35
FSHCX
JNJ

Dividends

FSHCX vs. JNJ - Dividend Comparison

FSHCX's dividend yield for the trailing twelve months is around 0.67%, less than JNJ's 3.34% yield.


TTM20242023202220212020201920182017201620152014
FSHCX
Fidelity Select Health Care Services Portfolio
0.67%0.71%0.35%0.23%0.21%0.76%0.27%0.12%0.11%0.16%1.91%3.52%
JNJ
Johnson & Johnson
3.34%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

FSHCX vs. JNJ - Drawdown Comparison

The maximum FSHCX drawdown since its inception was -57.77%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for FSHCX and JNJ. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%AugustSeptemberOctoberNovemberDecember2025
-26.56%
-14.32%
FSHCX
JNJ

Volatility

FSHCX vs. JNJ - Volatility Comparison

Fidelity Select Health Care Services Portfolio (FSHCX) has a higher volatility of 11.58% compared to Johnson & Johnson (JNJ) at 5.21%. This indicates that FSHCX's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
11.58%
5.21%
FSHCX
JNJ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab